Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfer Factor Oral Solution for Herpes Zoster
ChiCTR2600117507Phase 4Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dialyzable transfer factor in herpes zoster (HZ) (2 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Time to relief of herpes zoster symptoms and signs. Started Jan 2026; status: recruiting.
02
Drugs
dialyzable transfer factor
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2600117507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117507.